{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:31:19Z","timestamp":1793370679822,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004734.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,7,4]],"date-time":"2014-07-04T00:00:00Z","timestamp":1404432000000}}],"reference-count":113,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004734.pub4","type":"journal-article","created":{"date-parts":[[2014,7,4]],"date-time":"2014-07-04T12:06:07Z","timestamp":1404475567000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Aspirin and\/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia"],"prefix":"10.1002","volume":"2014","author":[{"given":"Paulien G","family":"de Jong","sequence":"first","affiliation":[{"name":"Academic Medical Center; Department of Vascular Medicine; Meibergdreef 9 Amsterdam Netherlands 1105 AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stef","family":"Kaandorp","sequence":"additional","affiliation":[{"name":"Westfriesgasthuis; Obstetrics and Gynaecology; Maelsonstraat 3 P.O. Box 600 Hoorn Noord Holland Netherlands 1620 AR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Di Nisio","sequence":"additional","affiliation":[{"name":"Academic Medical Center; Department of Vascular Medicine; Meibergdreef 9 Amsterdam Netherlands 1105 AZ"},{"name":"University \"G. D'Annunzio\" of Chieti-Pescara; Department of Medical, Oral and Biotechnological Sciences; via dei Vestini 31 Chieti Italy 66013"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00ebtte","family":"Goddijn","sequence":"additional","affiliation":[{"name":"Academic Medical Center University of Amsterdam; Center for Reproductive Medicine, Department of Obstetrics and Gynaecology; Meibergdreef 9 Amsterdam Netherlands 1100 DE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Middeldorp","sequence":"additional","affiliation":[{"name":"Academic Medical Center; Department of Vascular Medicine; Meibergdreef 9 Amsterdam Netherlands 1105 AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,7,4]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD004734.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/01443610802042688","article-title":"Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology","volume":"28","author":"Badawy","year":"2008","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0003|cit2","unstructured":"Clark P The Scottish pregnancy intervention study: the effect of low molecular weight heparin and aspirin therapy on recurrent pregnancy loss (ongoing trial) National Research Register (www.nrr.nhs.uk)"},{"issue":"21","key":"10.1002\/14651858.CD004734.pub4-BIB0002|cit3","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1182\/blood-2010-01-267252","article-title":"SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage","volume":"115","author":"Clark","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD004734.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.fertnstert.2005.12.068","article-title":"A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages","volume":"86","author":"Dolitzky","year":"2006","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD004734.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00404-007-0527-x","article-title":"Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study","volume":"278","author":"Fawzy","year":"2008","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004734.pub4-BIB0006|cit6","first-page":"146","article-title":"Recurrent fetal loss: prospective evaluation of the efficacy of three different thromboprophylaxis regimens: aspirin versus low molecular weight heparin versus low molecular weight heparin plus aspirin [abstract]","volume":"91","author":"Chistolini","year":"2006","journal-title":"Hematology Journal"},{"issue":"7","key":"10.1002\/14651858.CD004734.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3109\/14767058.2011.600366","article-title":"Efficacy of three different antithrombotic regimens on pregnancy outcome in pregnant women affected by recurrent pregnancy loss","volume":"25","author":"Giancotti","year":"2012","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"issue":"17","key":"10.1002\/14651858.CD004734.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage","volume":"362","author":"Kaandorp","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0009|cit9","unstructured":"Middeldorp S Aspirin and\/or low molecular weight heparin for women with unexplained recurrent miscarriage and\/or intra-uterine fetal death Netherlands Trial Register (http:\/\/www.trialregister.nl)"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0011|cit10","first-page":"A3","article-title":"Low molecular weight heparin in pregnant women with previous obstetrical complications. A multicenter, randomized trial","volume":"37 Suppl 1","author":"Martinelli","year":"2010","journal-title":"Pathophysiology of Haemostasis and Thrombosis"},{"issue":"14","key":"10.1002\/14651858.CD004734.pub4-BIB0010|cit11","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood-2011-11-391383","article-title":"Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial","volume":"119","author":"Martinelli","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD004734.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/humrep\/12.Suppl_2.191","article-title":"Low dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production","volume":"12","author":"Tulppala","year":"1997","journal-title":"Human Reproduction"},{"issue":"7","key":"10.1002\/14651858.CD004734.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/humrep\/12.7.1567","article-title":"Low-dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production","volume":"12","author":"Tulppala","year":"1997","journal-title":"Human Reproduction"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD004734.pub4-BIB0014|cit14","first-page":"S371","article-title":"A randomised controlled multicenter study: the effect of enoxaparin and\/or aspirin on prevention of recurrent miscarriage in women with or without thrombophilia, HABENOX-study","volume":"107","author":"Visser","year":"2009","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"2","key":"10.1002\/14651858.CD004734.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1160\/TH10-05-0334","article-title":"Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia - HABENOX*: a randomised multicentre trial","volume":"105","author":"Visser","year":"2011","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-7292(00)00202-2","article-title":"Low-molecular-weight heparin for thrombophilia in pregnant women","volume":"69","author":"Bar","year":"2000","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0049-3848(00)00413-8","article-title":"Effect of thromboprophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications","volume":"101","author":"Bar","year":"2001","journal-title":"Thrombosis Research"},{"issue":"3","key":"10.1002\/14651858.CD004734.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/107602960000600301","article-title":"Recurrent miscarriage syndrome due to blood coagulation protein\/platelet defects: prevalence, treatment and outcome results. DRW Metroplex Recurrent Miscarriage Syndrome Cooperative Group","volume":"6","author":"Bick","year":"2000","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0037-1613894","article-title":"Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin","volume":"83","author":"Brenner","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"issue":"3","key":"10.1002\/14651858.CD004734.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.fertnstert.2005.03.048","article-title":"Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study","volume":"84","author":"Brenner","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"11","key":"10.1002\/14651858.CD004734.pub4-BIB0021|cit21","first-page":"16a","article-title":"Enoxaparin treatment improves the gestational outcome of pregnant women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study [abstract]","volume":"102","author":"Brenner","year":"2003","journal-title":"Blood"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0022|cit22","first-page":"Abstract number","article-title":"Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study","volume":"1 Suppl 1","author":"Brenner","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD004734.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1538-7836.2004.01090.x","article-title":"Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study","volume":"3","author":"Brenner","year":"2005","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"11 Pt 1","key":"10.1002\/14651858.CD004734.pub4-BIB0024|cit24","first-page":"702a","article-title":"Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss. The LIVE-ENOX study","volume":"100","author":"Brenner","year":"2002","journal-title":"Blood"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD004734.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ajog.2004.09.049","article-title":"Efficacy of enoxaparin for improving pregnancy outcomes and uteroplacental blood flow in women with thrombophilia and recurrent pregnancy loss","volume":"191","author":"Thaler","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1538-7836.2003.00066.x","article-title":"Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia","volume":"1","author":"Carp","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD004734.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0015-0282(02)03222-3","article-title":"Preventing adverse obstetric outcomes in women with genetic thrombophilia","volume":"78","author":"Grandone","year":"2002","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD004734.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-0038-1653781","article-title":"Use of a low-molecular-weight heparin (enoxaparin) or of a phenformin-like substance (moroxydine chloride) in primary early recurrent aborters with an impaired fibrinolytic capacity","volume":"73","author":"Gris","year":"1995","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","article-title":"Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder","volume":"103","author":"Gris","year":"2004","journal-title":"Blood"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0030|cit30","doi-asserted-by":"crossref","unstructured":"Gris JC Chauleur C Faillie JL Baer G Mares P Fabbro-Peray P Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae: the pilot randomised controlled NOH-AP trial Thrombosis and Haemostasis 2010 771 9","DOI":"10.1160\/TH10-03-0167"},{"issue":"6","key":"10.1002\/14651858.CD004734.pub4-BIB0031|cit31","first-page":"1053","article-title":"Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial","volume":"106","author":"Gris","year":"2011","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/bmj.327.7411.368","article-title":"Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study","volume":"327","author":"Li","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD004734.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0015-0282(01)01819-2","article-title":"Low-dose aspirin is effective for treatment of recurrent miscarriage in patients with decreased coagulation factor XII","volume":"76","author":"Ogasawara","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"10","key":"10.1002\/14651858.CD004734.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/humrep\/15.10.2220","article-title":"Recurrent miscarriage-an aspirin a day?","volume":"15","author":"Rai","year":"2000","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD004734.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1538-7836.2008.03230.x","article-title":"Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial","volume":"7","author":"Rey","year":"2009","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"8","key":"10.1002\/14651858.CD004734.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1093\/humrep\/14.8.2106","article-title":"Habitual abortions in 678 healthy patients: investigation and prevention","volume":"14","author":"Reznikoff-Etievant","year":"1999","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0037|cit37","first-page":"Abstract number","article-title":"Modulation of systemic and placental hemostatic mechanisms by enoxaparin in women with gestational vascular complications","volume":"1 Suppl 1","author":"Sarig","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD004734.pub4-BIB0038|cit38","first-page":"406","article-title":"Treatment with enoxaparin adapted to the fertility programs in women with recurrent abortion and thrombophilia","volume":"61","author":"Sarto","year":"2001","journal-title":"Medicina"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0039|cit39","first-page":"655","article-title":"Birth outcomes in pregnant women treated with low-molecular-weight heparin","volume":"79","author":"Sorensen","year":"2000","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD004734.pub4-BIB0040|cit40","first-page":"267","article-title":"Thromboprophylaxis throughout pregnancy in women with previous history of recurrent miscarriage of unknown etiology","volume":"29","author":"Tzafettas","year":"2002","journal-title":"Clinical and Experimental Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1471-0528.2000.tb13240.x","article-title":"The effect of thromboprophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V mutation","volume":"107","author":"Younis","year":"2000","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"5","key":"10.1002\/14651858.CD004734.pub4-BIB0042|cit42","first-page":"548","article-title":"Evaluation of the efficacy of aspirin and low molecular weight heparin in patients with unexplained recurrent spontaneous abortions","volume":"12","author":"Zolghadri","year":"2010","journal-title":"Iranian Red Crescent Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD004734.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1160\/TH06-10-0574","article-title":"The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial","volume":"98","author":"Abou-Nassar","year":"2007","journal-title":"Thrombosis and Haemostasis"},{"issue":"11 Pt 1","key":"10.1002\/14651858.CD004734.pub4-BIB0044|cit44","first-page":"262","article-title":"The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia: a randomised trial","volume":"108","author":"Abou-Nassar","year":"2006","journal-title":"Blood"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD004734.pub4-BIB0045|cit45","first-page":"78","article-title":"The Thrombophilia in Pregnancy Prophylaxis Study (TIPPS): a multi-national randomized trial of dalteparin vs. no dalteparin to prevent pregnancy complications in pregnant thrombophilic women","volume":"11","author":"Rodger","year":"2013","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0049|cit46","unstructured":"Rodger MA TIPPS: Thrombophilia in pregnancy prophylaxis study ClinicalTrials.gov (accessed 21 May 2013) 2009"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004734.pub4-BIB0046|cit47","first-page":"8","article-title":"Prophylactic low molecular weight heparin (LMWH) during pregnancy is not associated with a decrease in bone mineral density (BMD) [abstract]","volume":"25","author":"Rodger","year":"2006","journal-title":"Hypertension in Pregnancy"},{"issue":"8","key":"10.1002\/14651858.CD004734.pub4-BIB0047|cit48","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1538-7836.2007.02634.x","article-title":"Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial","volume":"5","author":"Rodger","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"11","key":"10.1002\/14651858.CD004734.pub4-BIB0048|cit49","doi-asserted-by":"crossref","first-page":"Abstract no 548","DOI":"10.1182\/blood.V106.11.548.548","article-title":"Prophylactic low molecular weight heparin (LMWH) during pregnancy is not associated with a decrease in bone mineral density (BMD). The TIPPS (Thrombophilia in Pregnancy Prophylaxis Study) BMD substudy","volume":"106","author":"Rodger","year":"2005","journal-title":"Blood"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0050|cit50","unstructured":"Rodgers M Thrombophilia in pregnancy prophylaxis study (TIPPS) Ottawa Health Research Institute (http:\/\/www.ohri.ca)"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD004734.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1016\/j.fertnstert.2012.07.699","article-title":"Low molecular weight heparin (LMWH) for treatment of recurrent miscarriage negatively tested for anti phospholipid antibodies: A randomized controlled trial","volume":"98","author":"Salman","year":"2012","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1055\/s-0028-1088777","article-title":"Therapy with dalteparin for habitual abortion - presentation of the ETHiG II-Studie","volume":"68","author":"Kamin","year":"2008","journal-title":"Geburtshilfe und Frauenheilkunde"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0055|cit53","unstructured":"Schleussner E Effectiveness of dalteparin therapy as intervention in recurrent pregnancy loss http:\/\/controlled-trials.com"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004734.pub4-BIB0053|cit54","first-page":"S220","article-title":"Low molecular weight heparin for the prevention of habitual abortion - introduction of the multicentre study EThIG2 and discussion of the current data","volume":"286","author":"Schleussner","year":"2012","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004734.pub4-BIB0054|cit55","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/S0049-3848(13)70035-5","article-title":"Low-molecular-weight heparin in recurrent pregnancy loss-Results of the ETHIG II study","volume":"131","author":"Schleussner","year":"2013","journal-title":"Thrombosis Research"},{"issue":"9575","key":"10.1002\/14651858.CD004734.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD004734.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD004734.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejogrb.2010.02.015","article-title":"Recurrent miscarriage: Are three miscarriages one too many? Analysis of a Scottish population-based database of 151,021 pregnancies","volume":"150","author":"Bhattacharya","year":"2010","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/oxfordjournals.humrep.a137135","article-title":"Cytogenetic studies in couples experiencing repeated pregnancy losses","volume":"5","author":"Braekeleer","year":"1990","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1093\/humrep\/14.11.2868","article-title":"A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage","volume":"14","author":"Brigham","year":"1999","journal-title":"Human Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD004734.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/humupd\/dmr028","article-title":"The prevalence of congenital uterine anomalies in unselected and high-risk populations: a systematic review","volume":"17","author":"Chan","year":"2011","journal-title":"Human Reproduction Update"},{"issue":"4","key":"10.1002\/14651858.CD004734.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.fertnstert.2004.12.018","article-title":"Evidence-based investigations and treatments of recurrent pregnancy loss","volume":"83","author":"Christiansen","year":"2005","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.gco.0000193011.73405.07","article-title":"Evidence-based investigations and treatments of recurrent pregnancy loss","volume":"18","author":"Christiansen","year":"2006","journal-title":"Current Opinion in Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/oxfordjournals.humrep.a138703","article-title":"An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases","volume":"9","author":"Clifford","year":"1994","journal-title":"Human Reproduction"},{"issue":"10","key":"10.1002\/14651858.CD004734.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/j.1538-7836.2010.04015.x","article-title":"Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy","volume":"8","author":"Cohn","year":"2010","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00001703-199510000-00006","article-title":"Recurrent pregnancy loss","volume":"7","author":"Cook","year":"1995","journal-title":"Current Opinion in Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0002-9378(97)70205-9","article-title":"Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction","volume":"177","author":"Dizon","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD004734.pub4-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002859.pub2","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant","author":"Empson","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/bmj.315.7099.32","article-title":"Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice","volume":"315","author":"Everett","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00006250-200212000-00032","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/bmj.38498.669595.8F","article-title":"Selective chromosome analysis in couples with two or more miscarriages: case-control study","volume":"331","author":"Franssen","year":"2005","journal-title":"BMJ"},{"issue":"Suppl","key":"10.1002\/14651858.CD004734.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1378\/chest.119.1_suppl.122S","article-title":"Use of antithrombotic agents during pregnancy","volume":"119","author":"Ginsberg","year":"2001","journal-title":"Chest"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0073|cit73","first-page":"568","article-title":"Complications of induced abortion and miscarriage in three African Countries: a hospital-based study among WHO collaborating centres","volume":"80","author":"Goyaux","year":"2001","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD004734.pub4-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003511.pub2","article-title":"Progestogen for preventing miscarriage","author":"Haas","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0075|cit75","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0076|cit76","first-page":"6","volume-title":"Spontaneous Abortion","author":"Huisjes","year":"1984"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199110103251503","article-title":"Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study","volume":"325","author":"Infante-Reviard","year":"1991","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004734.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.fertnstert.2009.01.166","article-title":"Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses","volume":"93","author":"Jaslow","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1093\/humrep\/del150","article-title":"Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage","volume":"21","author":"Jauniaux","year":"2006","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM199901073400102","article-title":"Increased frequency of genetic thrombophilia in women with complications of pregnancy","volume":"340","author":"Kupferminc","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD004734.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial","volume":"36","author":"Laskin","year":"2009","journal-title":"Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD004734.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0022-3999(95)00579-X","article-title":"Miscarriage as a traumatic event: a review of the literature and new implications for intervention","volume":"40","author":"Lee","year":"1996","journal-title":"Journal of Psychosomatic Research"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD004734.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jama.295.9.1050","article-title":"Management of antiphospholipid antibody syndrome: a systematic review","volume":"295","author":"Lim","year":"2006","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1538-7836.2006.01839.x","article-title":"The natural course of women with recurrent fetal loss","volume":"4","author":"Lindqvist","year":"2006","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1055\/s-0037-1615891","article-title":"Pregnancy loss in the antiphospholipid syndrome","volume":"82","author":"Lockshin","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD004734.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bpobgyn.2006.11.007","article-title":"Psychological morbidity following miscarriage","volume":"21","author":"Lok","year":"2007","journal-title":"Best Practice & Research. Clinical Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"736","DOI":"10.7326\/0003-4819-130-9-199905040-00013","article-title":"Increased risk for fetal loss in carriers of the factor V Leiden","volume":"130","author":"Meinardi","year":"1999","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1538-7836.2007.02501.x","article-title":"Thrombophilia and pregnancy complications: cause or association?","volume":"5 Suppl 1","author":"Middeldorp","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"6","key":"10.1002\/14651858.CD004734.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1055\/s-2007-985752","article-title":"Thrombophilia: an update","volume":"33","author":"Middeldorp","year":"2007","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"2","key":"10.1002\/14651858.CD004734.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/humrep\/15.8.1830","article-title":"Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?","volume":"15","author":"Mousa","year":"2000","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0094|cit94","volume-title":"Report on Maternal Deaths in Australia 1994-96. Canberra","author":"National Health and Medical Research Council","year":"2001"},{"issue":"2","key":"10.1002\/14651858.CD004734.pub4-BIB0095|cit95","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000112.pub2","article-title":"Immunotherapy for recurrent miscarriage","author":"Porter","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(96)04125-6","article-title":"Increased fetal loss in women with heritable thrombophilia","volume":"348","author":"Preston","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/oxfordjournals.humrep.a136224","article-title":"Antiphospholipid antibodies and beta2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive approach","volume":"10","author":"Rai","year":"1995","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1471-0528.1996.tb09887.x","article-title":"Placental thrombosis and second trimester miscarriage in association with activated protein C resistance","volume":"103","author":"Rai","year":"1996","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0100|cit100","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4471-1658-5_4","article-title":"A prospective study of spontaneous abortion","volume-title":"Early Pregnancy Loss: Mechanisms and Treatment","author":"Regan","year":"1988"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0101|cit101","unstructured":"The Cochrane Collaboration Review Manager (RevMan) 2012"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(03)12771-7","article-title":"Thrombophilic disorders and fetal loss: a meta-analysis","volume":"361","author":"Rey","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD004734.pub4-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"Thrombophilia in pregnancy: a systematic review","volume":"132","author":"Robertson","year":"2006","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-4471-1658-5_16","article-title":"Placental pathology in spontaneous miscarriage","volume-title":"Early Pregnancy Loss: Mechanisms and Treatment","author":"Rushton","year":"1988"},{"issue":"3","key":"10.1002\/14651858.CD004734.pub4-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0038-1650282","article-title":"The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women","volume":"75","author":"Sanson","year":"1996","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low-molecular-weight heparin in pregnancy. A systematic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0140-6736(90)92159-F","article-title":"Recurrent miscarriage: definition and epidemiology","volume":"336","author":"Stirrat","year":"1990","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD004734.pub4-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/humrep\/deq089","article-title":"Consecutive or non-consecutive recurrent miscarriage: is there any difference in carrier status?","volume":"25","author":"Boogaard","year":"2010","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD004734.pub4-BIB0109|cit109","unstructured":"van den Boogaard E Cohn DM Korevaar JC Dawood F Vissenberg R Middeldorp S Number and sequence of preceding miscarriages and maternal age for the prediction of antiphospholipid syndrome in women with recurrent miscarriage Fertility and Sterility 10.1016\/j.fertnstert.2012.09.002."},{"issue":"2","key":"10.1002\/14651858.CD004734.pub4-BIB0110|cit110","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003580","article-title":"Heparin for pregnant women with acquired or inherited thrombophilias","author":"Walker","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD004734.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/humrep\/dep343","article-title":"The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009","volume":"24","author":"Zegers-Hochschild","year":"2009","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD004734.pub4-BIB0112|cit112","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004734.pub2","article-title":"Aspirin or anticoagulants for the treatment of recurrent miscarriage in women without antiphospholipid syndrome","author":"Nisio","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD004734.pub4-BIB0113|cit113","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004734.pub3","article-title":"Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome","author":"Kaandorp","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004734.pub4\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T17:44:15Z","timestamp":1697823855000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004734.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Pregnancy and Childbirth Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,4]]},"references-count":113,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004734.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,4]]}}}